Add Company
Join Now

Melanoma Institute Australia Revenue and Competitors

License our Company Data API

Crows Nest, AU

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Melanoma Institute Australia's estimated annual revenue is currently $16.2M per year.(i)
  • Melanoma Institute Australia's estimated revenue per employee is $112,200

Employee Data

  • Melanoma Institute Australia has 144 Employees.(i)
  • Melanoma Institute Australia grew their employee count by 7% last year.

Melanoma Institute Australia's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CIOReveal Email/Phone
3
Clinical Trials Research OfficerReveal Email/Phone
4
EA to Co Medical DirectorReveal Email/Phone
5
Dermatologist, Associate ProfessorReveal Email/Phone
6
surgeonReveal Email/Phone
7
Clinical Research AssociateReveal Email/Phone
8
Software EngineerReveal Email/Phone
9
Medical WriterReveal Email/Phone
10
Clinical Trials CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M19N/AN/AN/A
#2
$16M143N/AN/AN/A
#3
$8.5M83-1%N/AN/A
#4
$9.4M9218%N/AN/A
#5
$7.9M778%N/AN/A
#6
$11M10816%N/AN/A
#7
$9.4M9210%N/AN/A
#8
$15.8M1417%N/AN/A
#9
$16M1437%N/AN/A
#10
$25.5M22721%N/AN/A
Add Company

What Is Melanoma Institute Australia?

Melanoma Institute Australia is a non-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education. Based in the Poche Centre, the world’s largest melanoma research and treatment centre, Melanoma Institute Australia is affiliated with The University of Sydney and St Vincent’s and Mater Health Sydney. Melanoma Institute Australia relies on the generosity of individuals, organisations and government funding to continue its ground-breaking work into this potentially devastating cancer. Melanoma research, Melanoma treatment, Melanoma education

keywords:N/A

N/A

Total Funding

144

Number of Employees

$16.2M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Melanoma Institute Australia News

2022-04-17 - Nivolumab + Relatlimab Continues Clinical Benefit in ...

... PhD, Chair of Melanoma Medical Oncology and Translational Research at the Melanoma Institute Australia at the University of Sydney,...

2022-04-13 - Labor’s pledge to tackle melanoma

Opposition Leader Anthony Albanese on Friday announced a $14.8 million grant over the forward estimates for Melanoma Institute Australia...

2022-03-30 - Global melanoma rate to increase by 50% by 2040, researchers predict

Australia's skin cancer rate rising in over 50s, but 'declining quite ... Melanoma Institute Australia last month released a report calling...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.1M1517%N/A
#2
$28M1597%N/A
#3
$44.9M168-1%N/A
#4
$27.9M1759%N/A
#5
$50.5M1895%N/A